Theravance Biopharma (TBPH) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Theravance Biopharma (TBPH) over the last 10 years, with Q3 2025 value amounting to -$11.27.
- Theravance Biopharma's Times Interest Earned rose 3451.03% to -$11.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.01, marking a year-over-year increase of 2528.58%. This contributed to the annual value of -$18.44 for FY2024, which is 2266.49% up from last year.
- Per Theravance Biopharma's latest filing, its Times Interest Earned stood at -$11.27 for Q3 2025, which was up 3451.03% from -$4.11 recorded in Q2 2025.
- Over the past 5 years, Theravance Biopharma's Times Interest Earned peaked at -$4.11 during Q2 2025, and registered a low of -$45.29 during Q1 2023.
- Over the past 5 years, Theravance Biopharma's median Times Interest Earned value was -$17.2 (recorded in 2024), while the average stood at -$17.99.
- In the last 5 years, Theravance Biopharma's Times Interest Earned tumbled by 93697.73% in 2021 and then surged by 8314.61% in 2025.
- Over the past 5 years, Theravance Biopharma's Times Interest Earned (Quarter) stood at -$26.28 in 2021, then dropped by 20.59% to -$31.69 in 2022, then surged by 68.4% to -$10.02 in 2023, then crashed by 42.85% to -$14.31 in 2024, then rose by 21.27% to -$11.27 in 2025.
- Its Times Interest Earned stands at -$11.27 for Q3 2025, versus -$4.11 for Q2 2025 and -$22.45 for Q1 2025.